Efficacy, safety, and pharmacokinetics of rifaximin in pediatric patients with hepatic encephalopathy in Japan: An open-label study

Hepatology Communications · Published 2026-07-15 · DOI 10.1097/hc9.0000000000001002

Free full text

Authors (4)

Hideaki Okajima, Masashi Tagawa, Masaki Fujisawa, Kaoru Ueda

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Okajima, H., Tagawa, M., Fujisawa, M., et al. (2026). Efficacy, safety, and pharmacokinetics of rifaximin in pediatric patients with hepatic encephalopathy in Japan: An open-label study. Hepatology Communications. https://doi.org/10.1097/hc9.0000000000001002

Related articles

• CRISPLD2 protects against liver inflammation and fibrosis via GRP78 to repress HMGB1/TLR4 axis–mediated STING palmitoylation · Hepatology Communications · 2026 · Same journal
• Neoadjuvant therapy in primary liver cancer: From the missing piece to a new paradigm · Hepatology Communications · 2026 · Same journal
• Prospective validation of a real-time natural language processing pipeline for the extraction of elastography results from electronic health record data · Hepatology Communications · 2026 · Same journal
• Reply: High mortality at safety-net hospitals for patients with cirrhosis · Hepatology Communications · 2026 · Same journal
• Multi-threshold analysis of the ELF Test versus histology for prognostication of disease progression and regression in MASH · Hepatology Communications · 2026 · Same journal
• Manufacturing and electrostatic surface optimization of CAR-T cells improve therapeutic efficacy in liver malignancies · Hepatology Communications · 2026 · Same journal
• IL15-mediated crosstalk between LSECs and CD8⁺ tissue-resident memory T cells drives alcohol-associated hepatitis · Hepatology Communications · 2026 · Same journal
• Contemporary global epidemiology of cirrhosis · Hepatology Communications · 2026 · Same journal
• The role of ammonia in chronic liver disease · Hepatology Communications · 2026 · Same journal
• The contemporary epidemiology, causes, and management of drug-induced liver injury · Hepatology Communications · 2026 · Same journal